Sweet's Syndrome: case report of a rare occurrence
DOI:
https://doi.org/10.33448/rsd-v10i15.22925Keywords:
Sweet's Syndrome; Corticosteroids; Febrile Acute Neutrophilic Dermatosis; Neutrophil infiltration.Abstract
Sweet's syndrome (SS) is a rare systemic inflammatory condition, which is characterized by the sudden appearance of erythemoedematous cutaneous plaques and nodules, related to systemic symptoms and infiltration of mature neutrophils in histopathological studies. Currently, the disease is classified into three categories: classic (idiopathic), associated with malignancy and drug-induced, and the classic constitutes the majority of cases. In this context, we present a case of a 72-year-old man with a typical picture of the classic form of Sweet's Syndrome, where he presented regression of the lesions after 2 weeks of treatment, and in these cases the regression starts 72 hours after the start of corticosteroid therapy. systemic. Despite Sweet's Syndrome being a rare disease, with the diagnosis and proper therapeutic establishment and with the use of systemic corticotherapy, the results end up being extremely fast and favorable to its patients. Therefore, the diagnosis and classification of the form of Sweet's Syndrome provides an adequate therapeutic direction, considering that in cases in which they are induced by drugs or associated with cancer, there are only satisfactory and lasting therapeutic responses, when the treatment is carried out. of the underlying disease and discontinuation of the causative drug, respectively.
References
Bancu, L. A., Ureche, C., Craciun, N. M., & Marian, D. (2016). A case of Sweet’s syndrome associated with uveitis in a young male with ulcerative colitis. Roman J Morpholo Embryol, 57, 1145-7.
Calderón H, P., Águila B, V., & Manfredi S, J. (2017). Síndrome de Sweet: revisión de la literatura a propósito de un caso. Rev. Hosp. Clin. Univ. Chile, 85-89.
Chi, S., Leung, M., Carmichael, M., Royer, M., & Cho, S. (2017). Atypical Histiocyte-Rich Sweet’s Syndrome. Case reports in dermatological medicine, 2017.
Dong, R. J., Huang, S. Z., Upadhyay, P., Shrestha, S., Zhai, Y. J., & Li, Y. Y. (2020). Thalidomide in the treatment of Sweet's syndrome and eosinophilic folliculitis associated with immune reconstitution inflammatory syndrome. Frontiers in medicine, 6, 343.
Fujii, A., Mizutani, Y., Hattori, Y., Takahashi, T., Ohnishi, H., Yoshida, S., & Seishima, M. (2017). Sweet’s syndrome successfully treated with granulocyte and monocyte adsorption apheresis. Case reports in dermatology, 9(2), 13-18.
Graça-Santos, L., Kieselova, K., Montenegro-Sá, F., Guardado, J., & Morais, J. (2020). Comprometimento cardíaco na síndrome de sweet: um achado raro numa doença rara. Arquivos Brasileiros de Cardiologia, 115, 6-9.
Heath, M. S., & Ortega-Loayza, A. G. (2019). Insights into the pathogenesis of sweet's syndrome. Frontiers in immunology, 10, 414.
Juan, C. K., Shen, J. L., Yang, C. S., Liu, K. L., & Yen, C. Y. (2015). Sweet's syndrome associated with Mycobacterium kansasii infection in an immunocompetent woman. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 13(9), 921-923.
Kelly, L., Justine, S., Brandon, G., Sandra, H., & Gwyn, R. (2021). Sweet syndrome with bitter outcomes in cervical cancer: A case report. Gynecologic Oncology Reports, 36, 100749.
Lee, J. H., & Choi, H. J. (2016). Necrotising fasciitis by steroid‐induced Sweet's syndrome: a case report. International wound journal, 13(5), 1057.
Liaw, T. Y. (2017). A case of Sweet syndrome successfully treated by anti-inflammatory property of doxycycline. Journal of the Formosan Medical Association= Taiwan yi zhi, 116(9), 723-724.
Mollaeian, A., Roudsari, H., & Talebi, E. (2019). Sweet’s syndrome: A classical presentation of a rare disease. Journal of investigative medicine high impact case reports, 7, 2324709619895164.
Mudroch, S. M., Rohan, C., Conger, N. G., & Lindholm, D. A. (2020). Sweet Syndrome in an Elderly Man With Well-Controlled Human Immunodeficiency Virus. Cureus, 12(9).
Nelson, C. A., Stephen, S., Ashchyan, H. J., James, W. D., Micheletti, R. G., & Rosenbach, M. (2018). Neutrophilic dermatoses: pathogenesis, Sweet syndrome, neutrophilic eccrine hidradenitis, and Behçet disease. Journal of the American Academy of Dermatology, 79(6), 987-1006.
PĂtraŞcu, V., Geoloaica, L. G., & Ciurea, R. N. (2020). Recurrent Idiopathic Sweet Syndrome-Case Report and Literature Review. Current Health Sciences Journal, 46(1), 90.
ScottonI, M. F., TondinI, A. A. R., da FonsecaI, A. G. N., de SousaI, J. T., HaddadII, G. R., SilvaresIII, M. R. C., & StolfIII, H. O. (2016). Síndrome de Sweet clássica: relato de caso típico. Revista diagnóstico e tratamento• volume 21• edição, 20.
Siedlikowski, S. T., & Lacroix, J. D. (2019). Sweet’s syndrome and fistulizing Crohn’s disease: A case report. SAGE open medical case reports, 7, 2050313X19850968.
Smith, C. R., & Williams, P. (2017). Sweet's syndrome in a patient with chronic lymphocytic leukaemia. Case Reports, 2017, bcr-2017.
Ventura, M. M. (2007). O estudo de caso como modalidade de pesquisa. Revista SoCERJ, 20(5), 383-386.
Vithoosan, S., Thanushah, B., Piranavan, P., Gamlaksha, D., Karunatilake, H., & Jayanaga, A. (2019). A rare case of Sweet syndrome secondary to melioidosis. BMC dermatology, 19(1), 1-4.
Yeom, S. D., Ko, H. S., Moon, J. H., Kang, M. J., Byun, J. W., Choi, G. S., & Shin, J. (2017). Histiocytoid Sweet syndrome in a child without underlying systemic disease. Annals of dermatology, 29(5), 626-629.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Cleber Queiroz Leite; Brian França dos Santos; Messias Genézio Santana da Silva; Stefany Ohana Oliveira Costa Borges
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
